Galmed Pharmaceuticals (GLMD) Q3 2026 Earnings

8JulConfirmed
Q2 2025
Q3 2025
Q4 2025
Q3 2026
-0.89
-0.7
-0.52
-0.33

Details

Expected EPS
-0.38
Actual EPS
N/A
Surprise EPS
0.38
Surprise Percent
+100%

Description

Galmed Pharmaceuticals (GLMD) will report earnings of for Q3 2026 on July 08, 2026.

0 Comments

Share your thoughts